• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
COVID vaccination EOIs give general practices ‘a seat at the table’

COVID vaccination EOIs give general practices ‘a seat at the table’

The RACGP is encouraging practices to submit their expression of interest, along with any concerns around the proposed delivery and funding model.


Will the new COVID vaccine ads help curb hesitancy?

Will the new COVID vaccine ads help curb hesitancy?

The $24 million campaign is aimed at reassuring Australians that the vaccines used in the rollout are safe and effective.


Opinion versus evidence: Searching for vaccine certainty

Opinion versus evidence: Searching for vaccine certainty

Dr Natasha Yates examines the issue of navigating data, misinformation and vaccine hesitancy among patients and healthcare workers.


Pfizer COVID vaccine first to be approved in Australia

Pfizer COVID vaccine first to be approved in Australia

The TGA has granted provisional approval ahead of next month’s planned rollout, which will now start in late February due to production delays.


Government seeks general practice EOIs for COVID vaccine rollout

Government seeks general practice EOIs for COVID vaccine rollout

GPs will form the backbone of ‘one of the greatest logistical exercises’ in Australian history.


It’s crucial COVID vaccine hesitancy among health workers is addressed

It’s crucial COVID vaccine hesitancy among health workers is addressed

Deputy Chair for the Collaboration on Social Science and Immunisation Associate Professor Holly Seale reveals where to start.


From the UK COVID frontline: what GPs can expect from the vaccine rollout

From the UK COVID frontline: what GPs can expect from the vaccine rollout

GP Dr Colin Fitzpatrick talks to newsGP about coordinating the delivery of Pfizer/BioNTech vaccines across 110 Northern Ireland aged care facilities, and why they may not be suited to a nationwide rollout.


COVID vaccine restrictions possible following elderly deaths in Norway

COVID vaccine restrictions possible following elderly deaths in Norway

But experts have called for calm, as the connection between the Pfizer/BioNtech vaccine and mortality in frail older people remains unclear.


Efficacy rate alone not enough to determine overall value of a vaccine

Efficacy rate alone not enough to determine overall value of a vaccine

Many have highlighted AstraZeneca’s apparent 62% efficacy as a reason for Australia to seek out alternatives, but the candidate has a number of other significant advantages.


How important are COVID vaccine efficacy rates?

How important are COVID vaccine efficacy rates?

Experts weigh in on whether greater investment in candidates with a higher efficacy rate would actually provide greater promise of elimination.


  • Previous
  • ...
  • 37
  • 38
  • 39
  • ...
  • Next
Pages: 39 of 47
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807